| Phytochemical Name : Cytisine |
| PCNDIDC0330 |
| Pubchem CID : 10235 |
| Molecular formula: C11H14N2O |
| Canonical SMILES : C1C2CNCC1C3=CC=CC(=O)N3C2 |
Synonymes : CYTISINE|485-35-8|Baptitoxine|Sophorine|Cytisinicline|Cytiton|Tabex|Baptitoxin|Laburnin|Ulexine|Ulexin|(-)-Cytisine|Cytitone|Tsitizin|Tabax|Cystisine|Citizin|Cytisin|Cytizin|Baphitoxine|6039 Sopharma|(1R,5S)-3,4,5,6-Tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one|(1r,5s)-1,2,3,4,5,6-Hexahydro-8h-1,5-Methanopyrido[1,2-A][1,5]diazocin-8-One|HSDB 3560|EINECS 207-616-0|Cytisine (-)|NSC 407282|NSC-407282|UNII-53S5U404NU|BRN 0083882|Cytisinicline [USAN]|53S5U404NU|CHEBI:4055|CHEMBL497939|5-24-02-00535 (Beilstein Handbook Reference)|(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one|CYTISINE (MART.)|CYTISINE [MART.]|1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-|1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-|1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-|(1R,9S)-7,11-diazatricyclo[7.3.1.0^{2,7}]trideca-2,4-dien-6-one|1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one|(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-1,5-METHANO-8H-PYRIDO-(1,2-A)(1,5)DIAZOCIN-8-ONE|(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO(1,2-A)(1,5)DIAZOCIN-8-ONE (CYTISINE)|SMR001233264|MLS003171607|citisiniclina|cytisiniclinum|MFCD00136048|NSC407282|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido-[1,2-a][1,5]diazocin-8-one|Cytisine- Bio-X|C5E|Prestwick_140|Cytisine ((+)-)|Tocris-1390|CYTISINE [HSDB]|CYTISINE [MI]|Prestwick3_000624|D08XPW|CYTISINICLINE [INN]|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-Methano-8H-Pyrido[1,2-A][1,5]Diazocin-8-One|BSPBio_000588|Cytisine, >=99%, powder|MLS002153916|MLS002222174|SCHEMBL161398|CYTISINICLINE [WHO-DD]|BPBio1_000648|GTPL5347|(1R,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|(1S,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|DTXSID00883395|1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one (cytisine)|Cytisine1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one|HMS2096N10|HMS2235L06|HMS3267D20|HMS3414N03|HMS3678L21|HMS3884L11|HY-N0175|TNP00030|BDBM50143282|HB2033|PDSP1_000461|s2287|WLN: T C666 A GVN LM&TTJ|AKOS000276818|AKOS015833102|CCG-208621|DB09028|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|NCGC00016463-01|NCGC00016463-02|NCGC00016463-03|NCGC00016463-04|NCGC00017171-01|NCGC00025138-01|NCGC00025138-02|NCGC00179513-01|AC-34317|AS-19539|BC164343|CAS-485-35-8|LS-59087|CS-0007888|SW219952-1|Cytisine, >=99.0% (HPLC), >=99%|EN300-224852|Q417343|BRD-K74186897-001-02-5|BRD-K74186897-001-04-1|BRD-K74186897-001-13-2|F9994-5373|Z1203159860|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R)-|(1R,9S)-7,11-diazatricyclo[7.3.1.0,2,7]trideca-2,4-dien-6-one|(1R,9S)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R-cis)-|(1R,5S)-1,2,3,4,5,6-hexahydro-1,5-m ethano-8H-pyrido[1,2-a][1,5]diazocin-8-one|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one|115051-74-6 |
| Structure | |
| 3D structure | 2D structure |
![]() |
| Log Po/w (iLOGP) : 2.400 |
| Log Po/w (XLOGP3) : 2.240 |
| Log Po/w (WLOGP) : 2.360 |
| Log Po/w (MLOGP) : 2.470 |
| Log Po/w (SILICOS-IT) : 2.260 |
| Consensus Log Po/w : 2.340 |

